Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Stew Leonard’s Wines & Spirits President Blake Leonard Talks Beverage Industry, Company Succession
08:03

Bob Hormats Talks Trump/Xi Summit
08:52

US Trade Representative Jamieson Greer Talks China Trade
13:52